bpc-157 wada ban Yes, another #cleansport anti-doping post. Realize the bias that I come from a competitive running background for the past 25+ years… If you don't stand for something, then you'll fall for everything… BPC-157 – What Athletes Need

The vitamin also influences the growth of strong nails and shiny hair

Common indications include trigeminal neuralgia, facial trauma, chronic neuropathic pain, or post-operative pain management following facial or oral surgical procedures

Prompt parenteral administration of vitamin B 12prevents progression of neurologic damage

Mike Reinold: Nice

Current availability status Semaglutide: FDA approved as Wegovy (weight loss) and Ozempic (diabetes) Prescription required Widely available through pharmacies Also available as research chemical Well-established sourcing Cagrilintide: NOT FDA approved (as of 2024) In Phase 3 clinical trials Not commercially available via prescription Only available as research chemical Limited vendors carry it CagriSema (combined product): Novo Nordisk's brand name In Phase 3 trials Not yet approved Anticipated FDA review 2025-2026 Will require prescription when approved Research chemical sourcing For semaglutide: Many established research chemical vendors Quality varies significantly Third-party testing essential Typical cost: $150-300 per 5mg vial Lasts 2-4 weeks at 2.4mg dose For cagrilintide: Very limited vendors currently Newer peptide, less available Quality even more variable Higher cost due to scarcity: $200-400 per 2.4mg vial Many vendors don't carry it yet Quality verification: Certificate of Analysis (COA) required Purity should be 95% Recent testing (within 6 months) Batch number matching Established vendor reputation Red flags: No testing documentation Suspiciously cheap prices New, unknown vendors Poor communication Inconsistent product quality reports See our best peptide vendors , are peptides legal , and research vs pharmaceutical peptides

These are applications where the regulatory pathway is shorter, the safety bar is lower (topical and ophthalmic versus systemic), and the commercial route does not require a full drug approval for systemic use